Faron Pharmaceuticals

About:

Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.

Twitter/X: FaronPharm

Top Investors: European Innovation Council, Business Finland, U.S. Department of Defense, IPF Partners, Leukemia & Lymphoma Society

Description:

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Total Funding Amount:

$66.3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Turku, Western Finland, Finland

Founded Date:

2006-10-01

Contact Email:

markku.jalkanen(AT)faronpharmaceuticals.com

Founders:

Markku Jalkanen

Number of Employees:

11-50

Last Funding Date:

2024-08-13

IPO Status:

Public

Industries: